Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
RNpharmGC A2019
Pharmacology Review for RN students Goodcare A2019
| Question | Answer |
|---|---|
| Condition caused by too much insulin, insufficient food intake, vomiting and diarrhea, and excessive exercise | Hypoglycemia |
| Symptoms of nervousness, tremors, headache, apprehension, sweating, cold and clammy skin, hunger; can lead to coma, death are associated with this glucose condition, | Hypoglycemia |
| This change in glucose level is treated by administering food/liquids if able to swallow. If unable to swallow, administer glucagon or IV fluids with 50% dextrose | Hypoglycemia |
| Glucose response caused by non-adherence, overeating, acute illness, or infection | Hyperglycemia |
| Condition associated with these symptoms: headache, nausea and vomiting, abdominal pain, dizziness, rapid pulse, rapid shallow respirations, acetone odor to breath, may cause coma and death | Hyperglycemia |
| Condition treated with administration of IV fluids; insulin; monitoring blood glucose, ketones, and potassium | Hyperglycemia |
| Patients allergic to sulfonamides may be allergic to this class of diabetic medication | sulfonylureas |
| The body's Key regulator of metabolism, required for entry of glucose into skeletal muscle and fat, needed for protein and lipid metabolism | Insulin |
| Onset: 10 minutes; peak: 1 to 3 hours; duration: 3 to 5 hours | Rapid-acting Insulin |
| Onset: 30 minutes; peak: 2.5 to 5 hours; duration: 5 to 10 hours | Short-acting Insulin |
| Insulin with Onset: 4 hours; peak: 4 to 12 hours; duration: 16 to 24 hours | Intermediate-acting Insulin |
| Insulin with Onset: 1 hour; no peak; duration: 24 hours | Long-acting Insulin |
| Classification for Metformin (Glucophage) | Biguanide |
| This antidiabetic medication Decreases hepatic glucose production by inhibiting glycogenolysis and gluconeogenesis, reduce adsorption of glucose from intestine, increase insulin sensitivity | Biguanide |
| Side effects of Nausea, vomiting, anorexia, abdominal cramps, flatulence with this antidiabetic medication | Biguanide |
| Serious adverse effects in this condition are malaise, myalgias, respiratory distress, hypotension, fruity smelling breath | Lactic acidosis |
| Medication group which stimulates the release of insulin from beta cells of pancreas | Sulfonylurea |
| Common adverse effects of this diabetic medication include Nausea, vomiting, anorexia, abdominal cramps, dairrhea | Metformin |
| Serious adverse effects Hypoglycemia, hepatotoxicity, blood dyscrasias, dermatologic reactions | Metformin |
| (glyburide) (chlorpropamide) (glyburide) ) (tolbutamide) (micronized glyburide) (tolazamide) (glipizide) (glimepiride) | Sulfonylurea agents |
| This specific class of oral diabetes medication,can cause a buildup of lactic acid levels. | Biguanides |
Created by:
TutorDavis17
Popular Nursing sets